18th Annual Meeting

October 31-November 2, 2003
Hyatt Regency
Bethesda, Maryland

  • Submit an abstract – deadline extended to August 18, 2003 at Noon, Central Standard Time
  • Register for Programs

Scientific Program Committee

Neil Berinstein, MD
Aventis Pasteur, Toronto, Canada
Janice Dutcher, MD
Our Lady of Mercy Medical Center, Bronx, New York
Francesco Marincola, MD
National Institutes of Health, Potomac, MD

An exciting program consisting of invited speakers and submitted abstracts from academic, government, and industrial investigators. The meeting not only provides an ideal venue to hear about the latest cutting edge translational research in the biological therapy of cancer, but also an outstanding opportunity to network with thought leaders and other professionals in the field, and present products and/or research via poster sessions and exhibits.

iSBTc 2003 Preliminary Program Outline

Friday
8:00am-8:45am
Kenote
Address

Natural Killer Cells and Innate Immunity
Peter Parham, PhD
8:45am-11:30am Joint
Session

Natural Killer Cells and Innate Immunity
Eric Long, PhD
and John Ortaldo, PhD, Chairs
11:30am-1:00pm Poster
Session/Exhibits Open
1:00pm-3:30pm
Plenary
Session

Dendritic Cells and Vaccines
Neil Berinstein, MD
and Jacques Banchereau, PhD, Chairs
3:45pm-5:30pm
Concurrent
Session I

Adoptive Immunotherapy
Patrick Hwu, MD
and David Stroncek, MD, Chairs
Concurrent
Session II

Pediatric Oncology
Jon Wigginton, MD
and Paul Sondel, MD, PhD, Chairs
Concurrent
Session III

Imaging
Peter Choyke, MD
and Steven Libutti, MD, Chair
s
Saturday
8:00am-8:45am
Keynote
Address

Inhibiting of Inflammatory Mediators
Alberto Mantovani, MD
8:45am-11:30am Joint
Session

Inhibiting of Inflammatory Mediators
Michael Lotze, MD
and Marion Nakada, PhD, Chairs
11:30am-1:00pm Poster
Session/Exhibits Open
1:00pm-2:20pm
Presidential
Session
4 abstracts
3:00pm-4:45pm
 
Concurrent
Session I

Cytokines-Polymorphisms
Francesco Marincola, MD
and Martin Howell, PhD, Chairs
Concurrent
Session II

Angiogenesis Monitoring Follow-Up
Steven Libutti, MD
and Raghu Kalluri, PhD, Chairs
Concurrent
Session III

Genomics
Ena Wang, MD
and Michael Bittner, PhD, Chairs
Sunday
8:00am-10:30am
Joint
Session

New Agents in Development
Janice Dutcher, MD
and Mel Sorensen, MD, Chairs

*Please note, this is a preliminary outline, topics and times are subject to change.

Confirmed Annual Meeting Faculty (as of August 8, 2003)

Wadih Arap, MD, PhD
MD Anderson Cancer Center
Houston, TX

Michael B. Atkins, MD
Beth Israel Deaconess Medical Center
Boston, MA

Frances Balkwill, PhD
Cancer Research UK Trans. Oncology Lab
London, United Kingdom

Jacques Banchereau, PhD
Baylor Institute for Immunology Research
Dallas, TX

Mark S. Berger, MD
GlaxoSmithKline
Collegeville, PA

Neil Berinstein, MD
Aventis Pasteur
Toronto, ON Canada

Michael L. Bittner, PhD
Translational Genomics Research Institute
Phoenix, AZ

Alexei Bogdanov, Jr., PhD
Massachusetts General Hospital
Charlestown, MA

Malcolm K. Brenner, MD, PhD
Baylor College of Medicine
Houston, TX

Peter L. Choyke, MD
Chief of Magnetic Resonance Imaging
NIH/CC/DRD
Bethesda, MD

Chaitanya Divgi, MD
Memorial Sloan Kettering Cancer Center
New York, NY

Janice P. Dutcher, MD
Our Lady of Mercy Medical Center
Bronx, NY

Grant Gallagher, PhD
Univ. of Medicine and Dentistry of New Jersey
Newark, NJ

Veronika Groh-Spies, MD
Fred Hutchinson Cancer Research Center
Seattle, WA

Jenny Gumperz, PhD
Brigham & Women’s Hospital
Boston, MA

Martin Howell, PhD
Southampton General Hospital
Southhampton, U K

Patrick Hwu, MD
National Cancer Institute
Bethesda, MD

Raghu Kalluri, PhD
Beth Israel Deaconess Medical Center
Boston, MA

Steven K. Libutti, MD
National Cancer Institute
Bethesda, MD

Eric O. Long, PhD
National Institutes of Health
Rockville, MD

Michael T. Lotze, MD
University of Pittsburgh School of Medicine
Pittsburgh, PA

Alberto Mantovani, MD
Mario Negri Institute of Pharmacological Research
Milan, Italy

Francesco Marincola, MD
National Institutes of Health
Potomac, MD

Cornelis Melief, MD
Leiden University Medical Centre
Leiden, Netherlands

Marian Nakada, PhD
Centocor Inc.
Malvern, PA

Richard J. O’Reilly, MD
Memorial Sloan Kettering Cancer Center
New York, NY

John R. Ortaldo, PhD
National Cancer Institute
Frederick, MD

Lini Pandite, MD
GSK Oncology
Research Triangle Park, NC

Drew Pardoll, MD, PhD
Johns Hopkins Univ. Schl of Medicine
Baltimore, MD

Peter Parham, PhD
Stanford University School of Medicine
Stanford, CA

Renata Pasqualini, PhD
MD Anderson Cancer Center
Houston, TX

Gregory E. Plautz, MD
Cleveland Clinic Foundation
Cleveland, OH

Paola Ricciardi-Castagnoli, PhD
University of Milano-Bioscience
Milano, Italy

Steven A. Rosenberg, MD, PhD
National Cancer Institute
Bethesda, MD

Paul Sondel, MD, PhD
University of Wisconsin
Madison, WI

Mel Sorensen, MD
GlaxoSmithKline
Collegeville, PA

David Spaner, MD, PhD
Toronto- Sunnybrook Regional Cancer Center
Toronto, Ontario

David Stroncek, MD
National Institutes of Health
Bethesda, MD

Ena Wang, MD
NIH/CC
Bethesda, MD

Jon M. Wigginton, MD
National Cancer Institute
Frederick, MD

George D. Yancopoulos, MD, PhD
Regeneron Pharmaceuticals, Inc.
Tarrytown, NY

Elad Ziv, MD
University California-San Francisco
San Francisco, CA

 

Registration Fees

Early
Registration
(before Aug. 15)
Advance
Registration
(Aug. 16-Sept. 15)
Regular
Registration
(Sept. 16-Nov. 2)
One Day
Reg. Fees
Members
$430
$440
$460
$155
Non-Members
$495
$505
$525
$185
Allied Health Professionals
$270
$280
$300
$110
Students/
Fellows-in-Training
$225
$100